BioSpace News Archive

iPharma Labs, Inc. (“iPharma”), a privately-held contract development research organization (CDRO) specializing in inhalation pharmaceutical development services, announced today the addition of two new board members, expansion of the senior management/advisory team and the implementation of GMP testing services. These achievements have contributed to the continued successful growth of iPharma. Inhaled Covid-19 Treatments - Expanding G

Dynatronics Corporation (NASDAQ : DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced preliminary unaudited net sales for the fiscal fourth quarter ended June 30, 2020 and the fiscal year ended June 30, 2020. Fourth Quarter & Year End 2020 Update Preliminary unaudited fourth quarter 2020 net sales are expected to be in the range of $7.9 million to $8.2 million, a 47% - 49% de

Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara” or the “Company”) (OTCQB:SMTI), a provider of wound and skin care products dedicated to improving patient outcomes, announced today an update on the impact of the COVID-19 pandemic on the company’s financial results and operations.

Caligor Coghlan Pharma Services to Distribute Strontium89 (Strontium Chloride Injection Sr-89 USP) Outside the United States Agreement opens international markets ahead of schedule under Named Patient Program

JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs and therapies with non-addictive pain-relieving properties, continues to broaden the medical and clinical competency of its scientific advisory board.

Balt announced it has received CE Mark Approval for its Silk Vista flow diverting stent to treat patients with unruptured intracranial aneurysms, enabling commercialization in over 30 countries in and around the European Union.

Asieris Pharmaceuticals (Asieris), a China -based biotech company with global aspirations to discover, develop and commercialize innovative drugs for the treatment of genitourinary tumors and related diseases, announced today it has received Clinical Trial Approval (CTA) from China’s National Medical Products Administration (NMPA) for th

With biopharmaceutical development heavily focused on specialized therapeutics, drug sponsors are increasingly turning to expert outsourcing partners to meet growing demand for complex fill and finish solutions.

BioLife Plasma Services, part of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, today announced the opening of a new plasma collection center in North Las Vegas to collect standard plasma from healthy donors.

Massive blocks of genes—inherited together ‘plug and play’ style—may play a larger role in evolutionary adaption than previously thought, according to new research in Nature.